LEBANON — In collaboration with the National Institutes of Health and Belgium-based viral vector manufacturer Exothera, a team of researchers at Dartmouth Health’s Dartmouth Hitchcock Medical Center and Dartmouth’s Geisel School of Medicine are working to develop the first intranasal COVID-19 vaccine brought to market.
Peter F. Wright, M.D., is an infectious disease and international health physician at Dartmouth Hitchcock Medical Center. (COURTESY PHOTO)
Led by DHMC infectious disease and international health physician Peter F. Wright, MD, this nasal-spray vaccine will not require refrigeration and does not need to be administered by a medical professional, making it a critical tool in the fight against COVID-19 in developing parts of the world.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.